Building confidence at scale in 4D‑Metabolomics with data quality, depth and connectivity in focus
Metabolomics is a core pillar of modern systems biology, offering deep insights into the dynamic metabolic phenotypes that underpin human health and disease. Realizing its full potential requires generating high-quality and reproducible representations of complex metabolomes and enabling accurate comparison among them.
In this SelectScience® TechTalk, Dr. Matthew Lewis, Bruker Daltonics' Vice President of Metabolomics & Lipidomics, makes the case that metabolomics advances when quality is in focus. With the timsMetabo™ and its 4D data richness as the foundation, he examines what it takes to achieve confidence at scale, employing advanced quality control to monitor measurement precision, annotation scoring to ensure accurate connection to biochemical processes, and hybrid workflows that allow quantitation and discovery to thrive on the same platform.
The timsMetabo's multidimensional, AI-ready data and the digital metabolome archive turns the question from: Have I ever seen this before? into an executable query, using MetaboScape to connect spectra and annotations across distinct studies. Dr. Lewis sets out how this connected future is taking shape, and why Bruker, as a full solutions provider, is best positioned to deliver it.
By registering, you will learn how this connected approach reduces re‑runs, strengthens data comparability across studies, and equips you to generate the robust, AI‑ready datasets that accelerate discovery and support more reliable systems‑level insights.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing [email protected].
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Speaker: Dr. Matthew Lewis (Vice President, Metabolomics & Lipidomics, Bruker Daltonics)
For the past 25 years, Dr. Matthew Lewis has pursued his interests in better understanding biochemical processes and improving the analytical tools and techniques used to measure them. At Imperial College London, he served as the chief operating officer of the UK's National Phenome Centre and head of the academic section of Bioanalytical Chemistry in the Faculty of Medicine. Here, he worked to advance the understanding of human disease phenotypes using advanced bioanalytical and data analysis techniques for metabolic profiling at a previously unprecedented scale.
Lewis transitioned to industry in 2022 to more directly further the development of research-enabling solutions through his role at Bruker Daltonics. He takes great pleasure in extensive engagement in interdisciplinary team science and large-scale scientific collaborations, supporting advancements in the fields of metabolomics and lipidomics.
